These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28930757)

  • 41. CCL21/CCR7 up-regulate vascular endothelial growth factor-D expression via ERK pathway in human non-small cell lung cancer cells.
    Sun L; Zhang Q; Li Y; Tang N; Qiu X
    Int J Clin Exp Pathol; 2015; 8(12):15729-38. PubMed ID: 26884842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
    Wang J; Li M; Chen D; Nie J; Xi Y; Yang X; Chen Y; Yang Z
    Minerva Med; 2017 Dec; 108(6):513-517. PubMed ID: 28889723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between the expression of chemokine receptors CCR7 and CXCR3, and lymph node metastatic potential in lung adenocarcinoma.
    Maekawa S; Iwasaki A; Shirakusa T; Kawakami T; Yanagisawa J; Tanaka T; Shibaguchi H; Kinugasa T; Kuroki M; Kuroki M
    Oncol Rep; 2008 Jun; 19(6):1461-8. PubMed ID: 18497951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-operative radiotherapy is beneficial for T1/T2 triple negative breast cancer patients with four or more positive lymph nodes.
    Chen L; Zhang J; Chen J; Liu L; Liang L; Shangguan Z; Wang D
    Oncotarget; 2017 Jun; 8(26):42917-42925. PubMed ID: 28476034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4.
    Xiong B; Lei X; Zhang L; Fu J
    Biomed Pharmacother; 2017 May; 89():1401-1408. PubMed ID: 28320108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CCR7 enhances TGF-β1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer.
    Ma H; Gao L; Li S; Qin J; Chen L; Liu X; Xu P; Wang F; Xiao H; Zhou S; Gao Q; Liu B; Sun Y; Liang C
    Oncotarget; 2015 Sep; 6(27):24348-60. PubMed ID: 26176983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Copy number variation in triple negative breast cancer samples associated with lymph node metastasis.
    Pariyar M; Johns A; Thorne RF; Scott RJ; Avery-Kiejda KA
    Neoplasia; 2021 Aug; 23(8):743-753. PubMed ID: 34225099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.
    Li M; Li A; Zhou S; Xu Y; Xiao Y; Bi R; Yang W
    BMC Cancer; 2018 Jan; 18(1):4. PubMed ID: 29291717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Survival impact and predictive factors of axillary recurrence after sentinel biopsy.
    Houvenaeghel G; Classe JM; Garbay JR; Giard S; Cohen M; Faure C; Charytansky H; Rouzier R; Daraï E; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Fraisse J; Dravet F; Chauvet MP; Goncalves A; Lambaudie E
    Eur J Cancer; 2016 May; 58():73-82. PubMed ID: 26971077
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer.
    Cassier PA; Treilleux I; Bachelot T; Ray-Coquard I; Bendriss-Vermare N; Ménétrier-Caux C; Trédan O; Goddard-Léon S; Pin JJ; Mignotte H; Bathélémy-Dubois C; Caux C; Lebecque S; Blay JY
    BMC Cancer; 2011 May; 11():213. PubMed ID: 21624121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7.
    Günther K; Leier J; Henning G; Dimmler A; Weissbach R; Hohenberger W; Förster R
    Int J Cancer; 2005 Sep; 116(5):726-33. PubMed ID: 15828050
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
    Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
    BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.
    Schmidt G; Meyberg-Solomayer G; Gerlinger C; Juhasz-Böss I; Herr D; Rody A; Liedtke C; Solomayer EF
    Arch Gynecol Obstet; 2014 Dec; 290(6):1221-9. PubMed ID: 25012601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
    Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
    Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer.
    Tsai J; Bertoni D; Hernandez-Boussard T; Telli ML; Wapnir IL
    Ann Surg Oncol; 2016 Oct; 23(10):3310-6. PubMed ID: 27401442
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of prognostic factors related to triple-negative breast cancer].
    Shen SJ; Sun Q; Zhou YD; Guan JH; Mao F; Lin Y; Peng L; Xu Y; Wang XF; Xia W; Yao R; Han SM
    Zhonghua Wai Ke Za Zhi; 2013 Nov; 51(11):1000-4. PubMed ID: 24444685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.